BackGlobeStar Therapeutics Overview

GlobeStar Therapeutics Operating Income

Operating Income for GSTC.

Quarterly Operating Income

$-193357.00
84.89% YoY

As of Jun 30, 2024

Annual Operating Income (TTM)

$-804594.00
57.12% YoY

Trailing 12 months ending Jun 30, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)